Anthracycline Topoisomerase Inhibitor [EPC]

2431 reported adverse events

Drugs of this class: (DAUNORUBICIN AND CYTARABINE) LIPOSOME

These side effects are most commonly reported by patients taking drugs of the Anthracycline Topoisomerase Inhibitor [EPC] class:

# Side effect Count
0 FEBRILE NEUTROPENIA 528
1 ACUTE MYELOID LEUKAEMIA 313
2 DEATH 244
3 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 217
4 PYREXIA 206
5 ACUTE MYELOID LEUKAEMIA RECURRENT 177
6 RASH 152
7 PNEUMONIA 151
8 SEPSIS 142
9 OFF LABEL USE 121
See all common reactions for Anthracycline Topoisomerase Inhibitor [EPC]

Drugs of the Anthracycline Topoisomerase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEUROLEUKAEMIOSIS 2 0.5000
1 CYTARABINE SYNDROME 32 0.4211
2 CLOSTRIDIUM TEST 11 0.3548
3 DELAYED HAEMATOPOIETIC RECONSTITUTION 2 0.2222
4 ACUTE POST ASTHMATIC AMYOTROPHY 1 0.1667
5 CATHETER SITE ECZEMA 1 0.1429
6 CORYNEBACTERIUM BACTERAEMIA 11 0.1294
7 BONE MARROW HAEMORRHAGE 1 0.1250
8 ANTI-HLA ANTIBODY TEST POSITIVE 2 0.1176
9 ACUTE MYELOID LEUKAEMIA REFRACTORY 15 0.0872
See all enriched reactions for Anthracycline Topoisomerase Inhibitor [EPC]